Life Science

A glycopeptide antitumor antibiotic that produces single and double-strand DNA breaks in tumor cells to interrupt their cell cycle has been used for the treatment of Hodgkin&rsquos lymphoma in combination with doxorubicin, squamous cell

A mixed antagonist at dopamine D2, D3, and serotonin 5-HT2A receptors (Kis = 0.14, 0.

A mixed antagonist at dopamine D2, D3, and serotonin 5-HT2A receptors (Kis = 0.14, 0.

A mixed antagonist at dopamine D2, D3, and serotonin 5-HT2A receptors (Kis = 0.14, 0.

A mixed antagonist at dopamine D2, D3, and serotonin 5-HT2A receptors (Kis = 0.14, 0.

Product Formulation: TRIS-HCl: 250 mM SDS: 8% pH: 6.8. Add mercaptoethanol according to protocol.

Product Formulation: TRIS-HCl: 250 mM SDS: 8% pH: 6.8. Add mercaptoethanol according to protocol.

A unique stain for reversibly staining protein on nitrocellulose and PVDF transfer membranes. BLOT-FastStain&trade only stains protein and leaves the background absolutely untouched and brilliant white resulting in high band visibility.

A selective inhibitor of FGFR4 (IC₅₀s = 3, 591, 493, and 150 nM for FGFR4, 1, 2, and 3, respectively) inhibits proliferation of HCC cells (EC₅₀s = 0.02-0.

A selective inhibitor of FGFR4 (IC₅₀s = 3, 591, 493, and 150 nM for FGFR4, 1, 2, and 3, respectively) inhibits proliferation of HCC cells (EC₅₀s = 0.02-0.

A selective inhibitor of FGFR4 (IC₅₀s = 3, 591, 493, and 150 nM for FGFR4, 1, 2, and 3, respectively) inhibits proliferation of HCC cells (EC₅₀s = 0.02-0.

A selective inhibitor of FGFR4 (IC₅₀s = 3, 591, 493, and 150 nM for FGFR4, 1, 2, and 3, respectively) inhibits proliferation of HCC cells (EC₅₀s = 0.02-0.